Surgery Partners (SGRY) Debt to Equity (2014 - 2026)

Surgery Partners (SGRY) has 13 years of Debt to Equity data on file, last reported at $2.2 in Q1 2026.

• Quarterly Debt to Equity rose 95.55% year-over-year to $2.2 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 (up 95.55% YoY) and the FY2025 annual result came in at $1.18, up 12.13% from the prior year.
• Debt to Equity grew to $2.2 in Q1 2026 per SGRY's latest filing, from $1.18 in the prior quarter.
• The five-year high for Debt to Equity was $2.2 in Q1 2026, with the low at $0.86 in Q2 2023.
• Average Debt to Equity over 5 years is $1.22, with a median of $1.05 recorded in 2024.
• Year-over-year, Debt to Equity slumped 43.07% in 2023 and surged 100.91% in 2025.
• Surgery Partners' Debt to Equity stood at $0.89 in 2022, then climbed by 2.58% to $0.91 in 2023, then advanced by 15.3% to $1.05 in 2024, then gained by 12.13% to $1.18 in 2025, then soared by 86.09% to $2.2 in 2026.
• Business Quant data shows SGRY's Debt to Equity at $2.2 in Q1 2026, $1.18 in Q4 2025, and $2.06 in Q3 2025.